Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
16,093,918
-
Share change
-
+1,664,893
-
Total reported value
-
$174,294,975
-
Price per share
-
$10.83
-
Number of holders
-
60
-
Value change
-
+$5,020,262
-
Number of buys
-
36
-
Number of sells
-
25
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q4 2018
As of 31 Dec 2018 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,093,918 shares of stock of the company.
Largest 10 holders included FMR LLC, Polaris Venture Management Co. V, L.L.C., Canaan Partners VIII LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, JENNISON ASSOCIATES LLC, Voya Investment Management LLC, CANNELL CAPITAL LLC, Vanguard Group Inc, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, and BlackRock Inc..
This table shows 61 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.